Holen Sie sich die Stockscreener-App
3.0637
1.13%
-0.0363
Niagen Bioscience Inc Aktie (NAGE) Neueste Nachrichten
Niagen Bioscience, Inc. (NASDAQ: NAGE) Share Price, NAGE Stock News, NAGE Share Price & Updates - Kalkine
Niagen Bioscience to Present at Longevity Investors Conference - Business Wire
Niagen Bioscience, Inc. (NASDAQ:NAGE) Given Average Recommendation of "Buy" by Brokerages - MarketBeat
NAGE Price History for Niagen Bioscience Stock - Barchart.com
Niagen Bioscience at Midwest IDEAS: cash-rich growth and drug bets - Investing.com India
Niagen Bioscience to Present at Nasdaq X LD Micro Inaugural SF Summit - finance.yahoo.com
Niagen (NAGE) Results at a Glance: Profit Per Share Falls Below Its Benchmark in Latest Trading; Market Response - vinanet.vn
Niagen Bioscience stock gains GNC, Sam’s Club distribution, Canaccord reiterates buy - Investing.com
Niagen Bioscience Leads The Way With 2 Promising Penny Stocks - Sahm
Supplement Retail Expansions - Trend Hunter
Niagen Bioscience expands Tru Niagen to GNC, Sam’s Club stores - Investing.com
Niagen Bioscience expands Tru Niagen to GNC, Sam’s Club stores By Investing.com - Investing.com India
Niagen Bioscience Expands Tru Niagen® Retail Footprint with GNC and Sam’s Club - New Castle News
Tieton Capital Management LLC Purchases New Position in Niagen Bioscience, Inc. $NAGE - MarketBeat
Niagen (NAGE) Results at a Glance: EPS Does Not Reach the Reported Estimate for the Current Session; Price Reaction: The Stock Gains 4.71%Earnings Stability Report - vinanet.vn
Niagen (NAGE): Closes 0.33% Higher at $3.05 on the Day; Range and Risk: the Supplied Trading Band Runs From $2.90 to $3.20 on the DayAndrews Pitchfork - vinanet.vn
Niagen Bioscience (NAGE) Eases to $3.02 as Support Level Comes into FocusLong Term Entry Picks - Vinanet
Niagen Bioscience (NAGE) Holds Above $2.9 Support as Shares Drift LowerArms Index - vinanet.vn
Niagen Bioscience to Present at Midwest IDEAS Investor Conference - Bitget
Niagen Bioscience at canaccord growth conference: cash, science and growth By Investing.com - Investing.com India
Niagen Bioscience at canaccord growth conference: cash, science and growth - Investing.com
Does Niagen Bioscience's (NAGE) Walmart NAD+ Push Redefine Its Healthy‑Aging Brand Narrative? - finance.yahoo.com
HC Wainwright Forecasts Lower Earnings for Niagen Bioscience - MarketBeat
Niagen Bioscience, Inc. (NAGE) Stock Analysis: A 297% Upside Potential Awaits Investor Attention - DirectorsTalk Interviews
Is Niagen Bioscience (NAGE) Quietly Recasting Its Brand Around E‑Commerce Scale And Clinical Proof - simplywall.st
Niagen Bioscience launches Tru Niagen on Walmart.com - Investing.com India
HC Wainwright Predicts Weaker Earnings for Niagen Bioscience - MarketBeat
Niagen Bioscience Launches Tru Niagen on Walmart.com, Expanding Access and Diversifying Its E-commerce Marketplace Presence - Yahoo Finance
NAGE Stock Price and Chart — NASDAQ:NAGE - TradingView
Sei Investments Co. Increases Holdings in Niagen Bioscience, Inc. $NAGE - marketbeat.com
Niagen Bioscience, Inc. $NAGE Holdings Boosted by Renaissance Technologies LLC - MarketBeat
Niagen Bioscience (NAGE) On New Aging Study And The Case For A Higher Fair Value - Yahoo Finance
Niagen Bioscience (NAGE) Stock Sinks As Profit Cushion Thins - simplywall.st
Q2 2026 Niagen Bioscience Inc Earnings Call Transcript - GuruFocus
CCORF Maintains Niagen Bioscience(NAGE.US) With Buy Rating, Maintains Target Price $10 - Moomoo
Niagen Bioscience, Inc. (NASDAQ:NAGE) Given Consensus Rating of "Buy" by Brokerages - MarketBeat
Niagen Bioscience Inc (NAGE) (Q2 2026) Earnings Call Highlights: - GuruFocus
Niagen Bioscience, Inc. Stock 12‑Month Price Target Cut to $12.08, Implies 248% Upside - TradingView
Earnings call transcript: Niagen Bioscience posts q2 2026 growth, lifts spending - Investing.com Canada
Niagen Bioscience (NASDAQ:NAGE) Announces Quarterly Earnings Results, Meets Expectations - MarketBeat
Is Niagen Bioscience Inc (NAGE) Undervalued After Q2 Earnings Mi - GuruFocus
Niagen Bioscience (NAGE) Meets Q2 Earnings Estimates - Yahoo Finance
Niagen Bioscience, Inc. 2026 Q2ResultsEarnings Call Presentation (NASDAQ:NAGE) 2026-08-04 - Seeking Alpha
Niagen Bioscience Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Niagen Bioscience: Q2 Earnings Snapshot - Barchart.com
Niagen Bioscience, Inc. (NAGE) Q2 FY2026 earnings call transcript - Yahoo Finance
Niagen Bioscience 2026: Revenue $29.79M, EPS $0.01— 10-Q Summary - TradingView
Press Release: Niagen Bioscience, Inc. Reports Second Quarter 2026 Financial Results - 富途牛牛
[10-Q] Niagen Bioscience, Inc. Quarterly Earnings Report - Stock Titan
Niagen Bioscience, Inc. Reports Second Quarter 2026 Financial Results - Yahoo Finance
Niagen Bioscience (NAGE) Earnings Date and Reports 2026 - MarketBeat
Niagen Bioscience selects Evotec for rare disease drug studies - Investing.com
Niagen Bioscience selects Evotec for rare disease drug studies By Investing.com - Investing.com Nigeria
Arrowstreet Capital Limited Partnership Buys 761,685 Shares of Niagen Bioscience, Inc. $NAGE - MarketBeat
0.29%
4.16%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):